1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Compliance

Sales of Drug-Spiked Nicotine Could Sink E-Cigarettes' Smoking Cessation Chances

 
• By Malcolm Spicer

Since Commissioner Gottlieb's appointment, US FDA has challenged END industry more aggressively to eliminate products and advertising targeting children and has said sales to minors could be a focal point of an FDA action to ban all e-cigarette sales. Finding pharmaceutical ingredients in liquid nicotine could make a general ban on e-cigarette sales more likely in addition to imperiling approval for a smoking cessation indication.

A Chinese firm is casting a shadow over electronic cigarettes' chances in the US to be approved as medical products for smoking cessation as well as potentially over the entire industry's future by selling liquid nicotine spiked with erectile dysfunction drugs.

A warning letter to Shanghai HelloCig Electronic Technology Co. Ltd. that US FDA published on Oct

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

Packaging Producers Dodging Oregon EPR Program Face Penalties, Shaming – Consultant

 
• By Eileen Francis

Single-use packaging producers obligated under Oregon’s Extended Producer Responsibility law who still haven’t registered with program facilitators will struggle at this point to meet the fast-approaching material-reporting deadline, but should nonetheless jump into the process, says EPR consultant Michael Washburn.

MoCRA Education Deficit; Regulation Still Unknown To Many Small US Beauty Firms, Imported Brands

 
• By Eileen Francis

Many small US and independent beauty brands are still unfamiliar with the Modernization of Cosmetics Regulation Act, as are owners of beauty brands based outside the US; the lack of education about the regulation is making many stakeholders at risk for non-compliance.

US FDA Updates MoCRA Registration Guidance To Answer Stakeholder Questions

 
• By Eileen Francis

FDA publishes an updated registration guidance in the Federal Register 12 December to answer outstanding questions by stakeholders, including whether a single FEI number can be used for multiple related facilities.

Beauty Industry Relief: WA State Forging ‘Alternative Paths To Compliance’ For Lead Limits Under TFCA

 
• By Eileen Francis

The Washington State Department of Ecology will take interim policy action by 1 January, 2025 that will provide manufacturers alternative paths to compliance with the 1ppm lead limit under the state’s Toxic Free Cosmetics Act, the agency announces. It also anticipates opening a rulemaking related to lead impurities in cosmetics in 2025.

More from Policy & Regulation

Stakeholders Hope US FDA’s Proposed Animal Test Phase-Out For Drugs Will Extend To OTCs, Cosmetics

 
• By Eileen Francis and Lauren Nardella

The US Food and Drug Administration has released a roadmap to adopt new approach methodologies in lieu of animal testing for monoclonal antibody therapies and other drugs, which may include OTC drugs though the proposal does not specifically include cosmetics.

Little Industry Opposition To FDA Plan To Remove Synthetic Dyes, Or Agreement They’re Unsafe

 
• By Malcolm Spicer

Dyes and colors which FDA says industries agree should no longer be used aren’t unsafe and are currently used only with the agency’s approval, industry stakeholders say. Center for Science in the Public Interest says the dyes are used “in tens of thousands of foods and beverages that are commonly consumed here in the United States.”

US FDA Finds Banned Cosmetic Ingredient Methylene Chloride In Gel Polish Removers

 
• By Lauren Nardella

Testing conducted by the US Food and Drug Administration has found several cosmetic products on the market that contain high levels of methylene chloride, a banned ingredient.